Latest Advances

  • Condition: Hemophilia A
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Activated Prothrombin Complex Concentrate to Emicizumab Therapy
  • Number of Patients: 1
  • Published —
The study researched the safety of switching from activated prothrombin complex concentrate to emicizumab therapy for an infant with hemophilia A.
  • Condition: Acquired Hemophilia A (AHA)
  • Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
  • Treatment Used: Therapeutic Plasma Exchange (TPE) Therapy
  • Number of Patients: 1
  • Published —
This article reviewed the case of a patient with acquired hemophilia A (bleeding disorder; AHA) treated with therapeutic plasma exchange (removes and replaces a patient's blood plasma; TPE) therapy.
  • Condition: Cystic fibrosis
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Vitamin K
  • Number of Patients: 70
  • Published —
The aim of the study was to assess the effects of vitamin K supplementation in people with cystic fibrosis.
  • Condition: Severe Combined Inherited Thrombophilia
  • Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • Treatment Used: Rivaroxaban
  • Number of Patients: 1
  • Published —
This case report discusses a patient diagnosed with severe combined inherited thrombophilia (clotting disorder) treated with rivaroxaban.
  • Condition: Abnormal Bleeding
  • Journal: International journal of hematology
  • Treatment Used: Tranexamic Acid
  • Number of Patients: 24
  • Published —
In this study, researchers evaluated the outcomes of tranexamic acid for the treatment of abnormal bleeding due to light chain amyloidosis.
  • Condition: Japanese Hemodialysis Patient with Acquired Factor V Deficiency Associated with Cefepime
  • Journal: Clinical laboratory
  • Treatment Used: Oral Prednisolone
  • Number of Patients: 1
  • Published —
This case report describes a Japanese hemodialysis patient who developed acquired factor V deficiency after cefepime administration treated with oral prednisolone.
  • Condition: hemophilia A and hemophilia A/B
  • Journal: Blood
  • Treatment Used: subcutaneous concizumab prophylaxis
  • Number of Patients: 53
  • Published —
The purpose of the study was to evaluate the efficacy and safety of daily subcutaneous concizumab prophylaxis in patients with hemophilia A and hemophilia A/B
  • Condition: acquired hemophilia A
  • Journal: The American journal of case reports
  • Treatment Used: Emicizumab
  • Number of Patients: 1
  • Published —
The purpose of the paper is to present a case of an 87-year old woman admitted with acquired hemophilia A who was transitioned to Emicizumab on discharge.
  • Condition: Hemophilia A
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Emicizumab
  • Number of Patients: 0
  • Published —
The study discussed the effectiveness of Emicizumab in treating Hemophilia A.
  • Condition: Intracranial bleeding with Factor?X deficiency
  • Journal: Transfusion
  • Treatment Used: Plasma-derived Factor?X therapy
  • Number of Patients: 1
  • Published —
The study researched the effects of an infant with Intracranial bleeding and a Factor?X deficiency.
  • Condition: Cerebellar Syndrome in PMM2 Congenital Disorder of Glycosylation (PMM2-CDG)
  • Journal: Annals of neurology
  • Treatment Used: Acetazolamide
  • Number of Patients: 24
  • Published —
This study evaluated the safety and effectiveness of acetazolamide in patients with cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
  • Condition: Acquired hemophilia A (AHA)
  • Journal: Thrombosis research
  • Treatment Used: Low dose of activated prothrombin complex concentrate (aPCC).
  • Number of Patients: 56
  • Published —
This prospective and retrospective study assessed the clinical outcomes of low dose activated prothrombin complex concentrate (aPCC) for patients with acquired hemophilia A (AHA) as a short term prophylaxis to reduce subsequent bleeds.
Showing 1-12 of 15